| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/06/2004 | US20040087030 Method for the regeneration of cotton |
| 05/06/2004 | US20040087029 Production of viral vectors |
| 05/06/2004 | US20040087028 Ecdysone-inducible adeno-associated virus expression vectors |
| 05/06/2004 | US20040087027 Plasmid sequences for diagnosis and treatment of hyperproliferative/cell proliferative disorders; antitumor agents |
| 05/06/2004 | US20040087026 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof |
| 05/06/2004 | US20040087025 Transfering genetic material into proliferating lymphocytes using phorbol ester, calcium ionophores and lymphocyte receptor/CD3 complexes; gene therapy |
| 05/06/2004 | US20040087024 Comprises polyethylenimine coupled to cyclodextrins; for cell transfection; kits |
| 05/06/2004 | US20040087014 Eukaryotic expression libraries and methods of use |
| 05/06/2004 | US20040087012 Nucleus export reporter system |
| 05/06/2004 | US20040087003 Methods and cells for improved production of polyketides |
| 05/06/2004 | US20040087002 Using attenuated viral sequence to develop vaccines to prevent porcine reproductive and respiratory syndrome in swine; immunotherapy |
| 05/06/2004 | US20040087001 Transgenic viral particles to enhance cell fusion and transfer genetic material into polymorphonuclear leukocytes (PMNL); gene therapy |
| 05/06/2004 | US20040087000 Isopenicillin N synthetase and deacetoxycephalosporin C synthetase enzymes and method |
| 05/06/2004 | US20040086998 Comprises nucleotide sequences coding regulatory elements and protein with trehalose-6-phosphate synthase activity for transformation and expression in yeast; heterologous gene expression and bioreactors |
| 05/06/2004 | US20040086997 Phytase polypeptides |
| 05/06/2004 | US20040086996 Method of screening compounds that inhibit lysophosphatidic acid acyltransferase |
| 05/06/2004 | US20040086993 Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same |
| 05/06/2004 | US20040086989 Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity |
| 05/06/2004 | US20040086983 Genetic engineered Escharichia, actinomycetes; screening libraries; hydroxylation aromatic acids, organonitrogen compounds |
| 05/06/2004 | US20040086982 Using transgenic bacillus to ferment vitamin b5, valine and isoleucine |
| 05/06/2004 | US20040086980 Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular RNA-protein fusion formation |
| 05/06/2004 | US20040086979 Preparing monoclonal antibody with reduced immunogenicity; diagnostic tools; immunotherapy |
| 05/06/2004 | US20040086978 Pancreas-derived plasminogen activator inhibitor |
| 05/06/2004 | US20040086977 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 05/06/2004 | US20040086976 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 05/06/2004 | US20040086974 Comprises human tumor suppressor protein for treatment and prevention of cell proliferative disorders; antitumor/anticarcinogenic/antiproliferative agents |
| 05/06/2004 | US20040086973 Calmodulin-dependent protein kinase inhibitor for treatment and prevention of nervous system disorders |
| 05/06/2004 | US20040086972 Directed evolution of microorganisms |
| 05/06/2004 | US20040086971 Comprises nucleotide sequences coding extracellular matrix protein for prevention and treatment of inflammatory, immune and thrombotic disorders |
| 05/06/2004 | US20040086969 Expressing heterologous polypeptides in rhodospirillum; bioreactors; vaccine development |
| 05/06/2004 | US20040086967 Comprises polynucleotide coding tumor markers proteins for diagnosis of pancreatic and colon cancers; antiproliferative agents; wound healing or tissue regeneration |
| 05/06/2004 | US20040086965 Casein peptide fragments with growth-influencing activity on cell cultures |
| 05/06/2004 | US20040086962 Methods and materials relating to gene expression |
| 05/06/2004 | US20040086961 Amino acid modified polypeptides |
| 05/06/2004 | US20040086960 Transgenic cell expressing human leukocyte antigen fusion proteins for induction of cytotoxic T cell responses against viral and tumor antigens; immunotherapy |
| 05/06/2004 | US20040086959 Using in vitro translation to generation heterologous proteins; bioreactors |
| 05/06/2004 | US20040086952 Monoclonal antibody comrpising affininty for 5-lipoxygenase activating polypeptide (FLAP) for diagnosis, prevention and treatment of inflamation, asthma and glomerulonephritis; gastric cytoprotective agents |
| 05/06/2004 | US20040086950 Structure in which biological material is fixed and method for manufacturing the same |
| 05/06/2004 | US20040086943 Coupling agent containing secordary amide groups |
| 05/06/2004 | US20040086940 Novel g protein-coupled receptor protein and dna thereof |
| 05/06/2004 | US20040086937 Screening for antagonists and/or inhibitors of bacterial propagation and infection; mimetics |
| 05/06/2004 | US20040086934 Comprises striamin polypeptide for identifying modulator for treatment and prevention of cardiovascular, tumor and muscle disorders |
| 05/06/2004 | US20040086933 Protein and gene involved in myocyte differentiation |
| 05/06/2004 | US20040086932 Universal gel and methods for use thereof |
| 05/06/2004 | US20040086931 Polypeptides and nucleic acids encoding same |
| 05/06/2004 | US20040086930 Simultaneous isolation and quanitation of DNA |
| 05/06/2004 | US20040086924 In vitro selection of signaling aptamers |
| 05/06/2004 | US20040086923 Comprises polypeptide with carbamoyl phosphate synthase (CPS) activity for identifying modulators which prevent and/or treat cancer and metabolic disorders |
| 05/06/2004 | US20040086921 Comprises nucleotide sequences coding membrane proteins for diagnosis and treatment of metabolic disorders |
| 05/06/2004 | US20040086919 Comprises regulatory nucleotide sequences for identifying novel therapeutic agents for treatment of breast, bone marrow, pain, arthritic, behavioral, depression and hematopoietic disorders |
| 05/06/2004 | US20040086918 Macromolecular protection assay |
| 05/06/2004 | US20040086915 Quantitative RT-PCR to AC133 to diagnose cancer and monitor angiogenic activity in a cell sample |
| 05/06/2004 | US20040086913 Human genes and gene expression products XVI |
| 05/06/2004 | US20040086912 Method for detecting foreign DNA in a host Genome |
| 05/06/2004 | US20040086911 Nucleotide sequences for treatment of autoimmune, tumor and viral diseases; gene expression inhibition |
| 05/06/2004 | US20040086906 Method of amplifying mrna and cdna in microquantities |
| 05/06/2004 | US20040086905 Lipid-associated molecules |
| 05/06/2004 | US20040086904 Identifying modulators which suppress synthesis of secreted and/or membrane protein for prevention and treatment of allergic,inflammatory, skin, cardiovascular, nervous system and cancer disorders |
| 05/06/2004 | US20040086903 Comprises nucleotide sequences coding promoter and retinoid carrier protein for identifying modulator for treatment of fertility disorders |
| 05/06/2004 | US20040086902 Comprises nucleotide sequences coding fructosyltransferase for preparation of fructooligosaccharides and difructose dianhydrides for use as dietetic food or animal feed additive |
| 05/06/2004 | US20040086900 Generating transgenic yeast coding heterologous phosphodiesterase for identifying modulators for treatment of cardiovascular, asthma, depression and thrombotic disorders |
| 05/06/2004 | US20040086899 Compromises nuclelotide sequences coding polypeptides associated with elongation of fatty acid chains for treatment and prevention of skin, cardiovascular, inflammatory, gastrointestinal, respiratory system and bone disorders |
| 05/06/2004 | US20040086898 Comprises nucleotide sequences coding g protein coupled receptor for identifying modulator for treatment and prevention of cardiovascular, respiratory, muscle, liver, gastrointestinal, urogenital and blood disorders |
| 05/06/2004 | US20040086897 Nanoparticle probes with Raman Spectroscopic fingerprints for analyte detection |
| 05/06/2004 | US20040086893 Gab2 (p97) gene and methods of use thereof |
| 05/06/2004 | US20040086890 DNA polymerases with reduced base analog detection activity |
| 05/06/2004 | US20040086884 Using gene-targeted double stranded RNA (dsRNA) to inhibit preferential gene expression in cells; targeted tissue gene therapy |
| 05/06/2004 | US20040086877 Multi-mode directi memory access controller and method |
| 05/06/2004 | US20040086870 Microfluidic system for analyzing nucleic acids |
| 05/06/2004 | US20040086869 Multi-array apparatus comprising flexible substrates for diagnostic screening of polynucleotide sequences |
| 05/06/2004 | US20040086863 Comprises pleckstrin homology domain-interacting protein (PHI Protein) for identifying modulator and treatment for cancer and insulin response disorders |
| 05/06/2004 | US20040086860 Methods of producing RNAs of defined length and sequence |
| 05/06/2004 | US20040086859 Identification of a dual specificity phosphate: dusp-10 |
| 05/06/2004 | US20040086858 Identification of new human gaba transporter |
| 05/06/2004 | US20040086857 Proliferative glomerular nephritis-associated gene |
| 05/06/2004 | US20040086855 Method for screening genes expressing at desired part |
| 05/06/2004 | US20040086853 Nucleic acids; polymerase chain reaction; immobilized to solid support |
| 05/06/2004 | US20040086851 Anticancer agents |
| 05/06/2004 | US20040086847 Cestrum yellow leaf curling virus promoters |
| 05/06/2004 | US20040086846 Using bacterial artificial chromosomes to propagate/replicate viral nucleotide sequences; gene therapy and genetic vaccines |
| 05/06/2004 | US20040086534 Method of decreasing the severity or frequency of a relapse of multiple sclerosis |
| 05/06/2004 | US20040086533 For inhibiting bacterial invasion via intestinal barrier containing live Bacillus subtilis cells as an active ingredient |
| 05/06/2004 | US20040086530 Transgenic plant or plant cell that, when consumed as a foodstuff in four or less feedings, elicits an anti-HBsAg boosting immune response that increases serum anti-HBsAg antibody levels at least four-fold |
| 05/06/2004 | US20040086525 Polynucleotide sequences of C. pneumoniae for use in preventing and treating Chlamydia infection |
| 05/06/2004 | US20040086523 Fusion proteins of mycobacterium tuberculosis |
| 05/06/2004 | US20040086522 Strategies to prevent autoimmune disease by vaccination with vaccines based upon Epstein-Barr virus |
| 05/06/2004 | US20040086520 CTL epitope analogs |
| 05/06/2004 | US20040086516 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 05/06/2004 | US20040086510 Binds to insulin responsive aminopeptidase or GLUT4 glucose transporter 4 therapeutic agent for treatment or prophylaxis of hyperglycemia or diabetes |
| 05/06/2004 | US20040086507 Antibody inhibiting vplf activity |
| 05/06/2004 | US20040086506 Polyvalent immunogen |
| 05/06/2004 | US20040086505 Derived from human placenta |
| 05/06/2004 | US20040086503 High-affinity human anti-IGF-IR antibodies that could be used to treat diseases in humans |
| 05/06/2004 | US20040086502 Has a binding affinity for a target antigen which is at least about two fold stronger than the binding affinity of the parent antibody for said antigen |
| 05/06/2004 | US20040086501 Protein having activity as an angiogenesis modulator |
| 05/06/2004 | US20040086500 Murabutide, an analog of muramyl dipeptide, induces the production of cytokines or other factors not identified to date, which have a suppressor activity on HIV |
| 05/06/2004 | US20040086490 Nucleic acid vector comprising a pair of adeno-associated virus 4 (AAV4) inverted terminal repeats and a promoter between the inverted terminal repeats |
| 05/06/2004 | US20040086489 Recombinant cytomegalovirus comprising a cytomegalovirus genome that comprises a heterologous nucleotide sequence encoding a heterologous chemokine receptor or ligand |
| 05/06/2004 | US20040086488 Retroviral vectors |
| 05/06/2004 | US20040086487 Prevention or the treatment of congestive heart failure or myocardial ishchemia by administering a sphingosine kinase, or an analogue, fragment, or derivative thereof |